【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Pharmaceuticals & Healthcare, Global, Deal Summary 7
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, February 2013 7
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, February 2013 9
2.2.1 Biogen Idec to Acquire Elan’s Interest in Multiple Sclerosis Drug Tysabri for $3.2 Billion 9
2.2.2 Cardinal Health to Acquire AssuraMed for Up to $2.07 Billion 10
2.2.3 Mylan to Acquire Agila Specialties from Strides Arcolab for Up to $1.85 Billion 10
2.2.4 Quintiles Transnational Files Registration Statement for IPO to Raise Up to $600 Million 10
2.2.5 Chiasma Enters into Licensing Agreement with Roche for Octreolin 11
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, February 2013 12
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, February 2013 13
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 14
3.1 Pharmaceuticals & Healthcare, Global, M&A, February 2013 14
3.1.1 Top M&A Deals in February 2013 15
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, September 2012–February 2013 16
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, February 2013 17
3.2.1 Top Equity Offering Deals in February 2013 18
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, September 2012 – February 2013 19
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, February 2013 20
3.3.1 Top PE/VC Deals in February 2013 21
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, February 2013 22
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, February 2013 23
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, September 2012 – February 2013 25
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, September 2012 – February 2013 26
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, February 2013 27
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, February 2013 27
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, September 2012 – February 2013 28
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), February 2013 29
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, February 2013 30
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), September 2012 – February 2013 31
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, September 2012 – February 2013 32
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), September 2012 – February 2013 33
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), September 2012 – February 2013 34
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2013 35
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2013 35
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), February 2013 36
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, February 2013 37
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, February 2013 37
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, February 2013 38
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), September 2012 – February 2013 39
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), September 2012 – February 2013 40
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), September 2012 – February 2013 41
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), September 2012 – February 2013 43
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 44
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, February 2013 44
6.1.1 Oncology – Deals of the Month 45
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, February 2013 47
6.2.1 Central Nervous System – Deals of the Month 48
6.3 Pharmaceuticals & Healthcare, Global, Immunology Deals, February 2013 49
6.3.1 Immunology – Deal of the Month 50
6.4 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, February 2013 51
6.4.1 Infectious Diseases – Deals of the Month 52
6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, February 2013 53
6.5.1 Metabolic Disorders – Deal of the Month 54
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, February 2013 55
6.6.1 Cardiovascular – Deal of the Month 56
6.7 Pharmaceuticals & Healthcare, Global, Respiratory, Deals, February 2013 57
6.7.1 Respiratory – Deal of the Month 58
7 Deal Summary by Geography 59
7.1 Pharmaceuticals & Healthcare, North America Deals, February 2013 59
7.1.1 North America – Deals of the Month 60
7.2 Pharmaceuticals & Healthcare, Europe, Deals, February 2013 62
7.2.1 Europe – Deals of the Month 63
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, February 2013 65
7.3.1 Asia-Pacific – Deals of the Month 66
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, February 2013 67
7.4.1 Rest of the World – Deals of the Month 68
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 69
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, September 2012 – February 2013 69
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, September 2012 – February 2013 70
9 Further Information 71
9.1 Methodology 71
9.2 About GlobalData 71
9.3 Contact Us 72
9.4 Disclosure information 72
9.5 Disclaimer 72
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：February 2013（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for February 2013 in Pharmaceuticals
■ 発行日：2013年3月12日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160588
■ 調査対象地域：グローバル
- 有機生鮮食品の世界市場2019-2023About this market The rising demand for healthy food among the global population will trigger the market’s growth in the forthcoming years. The growing use of synthetic chemical fertilizers and pesticides in food products often leads to several health issues including Cancer, Obesity, and other birth defects. As a result, many farmers are using pesticides and fertilizers with strong chemical compo …
- 自動車用スーパーチャージャーの世界市場：二段スクリュー式、遠心式In terms of units produced, Technavios market research analysts have predicted the global automotive supercharger market to grow at a CAGR of over 10% over the next four years. The global automotive supercharger market is expected to grow at a significant rate during the forecast period owing to the environmental advantages offered by superchargers. In addition, the growth of the global automotive …
- 尿路感染症(Urinary Tract Infections)：世界の治験レビュー2014年下半期版Urinary Tract Infections Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Urinary Tract Infections Global Clinical Trials Review, H2, 2014" provides data on the Urinary Tract Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Urinary Tract Infections. It includes an overview of the trial num …
- 世界の大型トラック市場This latest just-auto report edition offers a global review of the heavy trucks sector, its manufacturers, top markets, technologies and market forecasts. This global market study offers: Heavy trucks market size estimates Latest technologies and trends Manufacturer production and sales volumes and forecasts Profiles of the major players including their strategies and prospects Market size forecas …
- インドの呼吸装置市場India Respiratory Devices Market Outlook to 2021 Summary GlobalData’s new report, "India Respiratory Devices Market Outlook to 2021", provides key market data on the India Respiratory Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Humidifiers, Oxygen Concentrators, Ventilators, Nebulizers, Pos …
- イギリスの血液バンク市場2014This report provides an overview of the UK blood banking market, including sales and market shares of leading suppliers of blood typing, grouping and infectious disease screening tests, as well as test volume and sales forecasts by market segment.Table of ContentsBusiness Environment Market StructureMarket Size, Growth and Major Suppliers’ Sales and Market Shares &nbs …
- 電力レンタル付属品の世界市場2017-2021About Power Rental Accessories Rental power is used to meet peak load demand, base load supply, or as a standby. The need to provide uninterrupted power is a major factor driving the growth of the global power rental accessories market. Power rentals are more economical than maintaining a reserve plant. Thus, this factor has increased the demand for rental power over time. Technavio’s analysts for …
- Newfield Exploration Company：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Newfield Exploration Company Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Newfield Exploration Company Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an es …
- 歯科用レーザーの世界市場About Dental LasersDental lasers are modern dental care equipment used to perform precise and effective dental procedures. Dental lasers are applicable for all types of dental procedures mainly for soft tissue and hard tissue. The use of dental lasers help to expand, offer, and help both patients and dentists to perform and minimize the pain and recovery time. Technavio’s analysts forecast the glo …
- 慢性閉塞性肺疾患(COPD)治療薬の市場機会とパイプライン分析Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflam …
- 再生可能エネルギー投資の世界市場2016-2020About Renewable Energy Renewable energy is generated from natural resources that include wave, wind, biomass, solar, hydro, geothermal, and tidal power. National governments and corporate enterprises are making heavy investments to develop and enhance clean renewable energy sources. These resources produce large quantities of energy and avoid greenhouse gases that contribute to the climate change. …
- 2014年戦略提言：スペインの血液及びフローサイトメトリー市場Complete report $6,200. DataPack (test volumes, sales forecasts, supplier shares) $3,900.SummaryThis comprehensive report contains 255 pages, 34 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in Spanish hematology and flow cytometry markets during the next five years. The report explores business and …
- CDNセキュリティの世界市場予測（～2022年）“Increasing demand for CDN security to protect content against rising security attacks/threats is the key factor to drive the CDN security market.” The Content Delivery Network (CDN) security market is projected to grow from USD 1.93 billion in 2017 to USD 7.63 billion by 2022, at a CAGR of 31.6% during the forecast period. Factors such as rapidly rising instances of DDoS and application layer sec …
- Sonde Resources Corp.：石油・ガスの開発・生産動向及びコスト分析– Q4, 2012Sonde Resources Corp. Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary Sonde Resources Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
- 豆類成分の世界市場予測（～2023年）“The pulse ingredients market is projected to grow at a CAGR of 4.5% in terms of value.” The pulse ingredients market is estimated at USD 17.4 billion in 2018 and projected to grow at a CAGR of 4.5%, to reach USD 21.6 billion by 2023. The growth of the pulse ingredients market is driven by the rising demand for healthy and natural food ingredients in the food industry. The popularity of protein-ri …
